Amidst global thought leaders, change makers and CEOs of some of the biggest companies such as Pfizer, Abbott and Delta Airlines - our Founder and CEO, Mihir Shah was invited to the main-stage for a one-on-one exclusive interview and innovation showcase with Fortune's Senior Editor, Beth Kowitt
Title of the Interview > IN THE PALM OF YOUR HAND: INNOVATIONS IN WOMEN’S DIAGNOSTICS
Breast cancer is the second most common cancer diagnosis among women in the U.S., and early detection is key. Enter iBreastExam—an FDA-cleared, hand-held breast examination device that patients and doctors can use for routine clinical exams between scheduled mammograms. It’s a battery-powered, radiation-free early detection device that has been used in checkups for over 500,000 women in 10 countries, and a new distribution deal could mainstream it in the U.S. Will iBreastExam change the game?
Mihir Shah, Founder and President, UE LifeSciences Interviewer: Beth Kowitt, FORTUNE